Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
Katherine Ververis,1 Alison Hiong,1 Tom C Karagiannis,1,* Paul V Licciardi2,*1Epigenomic Medicine, Alfred Medical Research and Education Precinct, 2Allergy and Immune Disorders, Murdoch Childrens Research Institute, Melbourne, VIC, Australia*These authors contributed equally to this workAbstract: Hi...
Main Authors: | Ververis K, Hiong A, Karagiannis TC, Licciardi PV |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-02-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/histone-deacetylase-inhibitors-hdacis-multitargeted-anticancer-agents-a12289 |
Similar Items
-
HDACiDB: a database for histone deacetylase inhibitors
by: Murugan K, et al.
Published: (2015-04-01) -
Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 inhibitors
by: Regina Martínez, et al.
Published: (2020-03-01) -
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
by: Amila Suraweera, et al.
Published: (2018-03-01) -
Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents
by: Heba M. Hesham, et al.
Published: (2018-06-01) -
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
by: Marinella Zilli, et al.
Published: (2013-07-01)